Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0SR4T
|
||||
| Former ID |
DIB013630
|
||||
| Drug Name |
PHENSERINE TARTRATE
|
||||
| Synonyms |
N-Phenylcarbamic acid (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl ester L-tartrate; (-)-5-O-(N-Phenylcarbamoyl)eseroline L-tartrate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Preclinical | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H23N3O2
|
||||
| Canonical SMILES |
CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C
|
||||
| InChI |
1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1
|
||||
| InChIKey |
PBHFNBQPZCRWQP-QUCCMNQESA-N
|
||||
| CAS Number |
CAS 101246-66-6
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10261477, 14753533, 14900124, 26756608, 33513596, 46511524, 50040339, 57397101, 80863817, 87219185, 90341153, 93308100, 103064548, 103080958, 103274646, 113454006, 117554826, 121361311, 126522384, 127337068, 127337069, 134341073, 135169732, 135698170, 141832076, 152106740, 162247997, 162767949, 163564477, 172113464, 175426894, 175612430, 198973050, 198975219, 204361976, 227737638, 243695745, 252156912
|
||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [2], [3] | |
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| WikiPathways | Monoamine Transport | ||||
| Biogenic Amine Synthesis | |||||
| Acetylcholine Synthesis | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012344) | ||||
| REF 2 | An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Curr Alzheimer Res. 2005 Jul;2(3):281-90. | ||||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.